S100A9 promotes binding between ubiquitin specific peptidase‐10 (USP10) and phosphoglycerate mutase family member‐5 (PGAM5), leading to the stabilization of PGAM5, which increases reactive oxygen species levels and subsequently inducing the growth and metastasis of HCC. Here, S100A9 is linked to hepatocellular carcinoma.